Jeff Chen has been appointed Group Chief Innovation Officer and Head of Capital Markets
SINGAPORE, 18 February 2019 – Fullerton Healthcare Corporation Limited (“Fullerton Health” or the “Group”) is pleased to announce that Jeff Chen has been appointed Group Chief Innovation Officer and Head of Capital Markets, based in Hong Kong. As Group Chief Innovation Officer and Head of Capital Markets, Jeff will serve on the Leadership Team and report to David Sin, Co-Founder